<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32811467</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>An epidemiological analysis of Acute Flaccid Paralysis (AFP)&#xa0;surveillance in Kenya, 2016 to 2018.</ArticleTitle><Pagination><StartPage>611</StartPage><MedlinePgn>611</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">611</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-020-05319-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The poliovirus has been targeted for eradication since 1988. Kenya reported its last case of indigenous Wild Poliovirus (WPV) in 1984 but suffered from an outbreak of circulating Vaccine-derived Poliovirus type 2 (cVDPV2) in 2018. We aimed to describe Kenya's polio surveillance performance 2016-2018 using WHO recommended polio surveillance standards.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective secondary data analysis was conducted using Kenyan AFP surveillance case-based database from 2016 to 2018. Analyses were carried out using Epi-Info statistical software (version 7) and mapping was done using Quantum Geographic Information System (GIS) (version 3.4.1).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Kenya reported 1706 cases of AFP from 2016 to 2018. None of the cases were confirmed as poliomyelitis. However, 23 (1.35%) were classified as polio compatible. Children under 5 years accounted for 1085 (63.6%) cases, 937 (55.0%) cases were boys, and 1503 (88.1%) cases had received three or more doses of Oral Polio Vaccine (OPV). AFP detection rate substantially increased over the years; however, the prolonged health workers strike in 2017 negatively affected key surveillance activities. The mean Non-Polio (NP-AFP) rate during the study period was 2.87/ 100,000 children under 15&#x2009;years, and two adequate specimens were collected for 1512 (88.6%) AFP cases. Cumulatively, 31 (66.0%) counties surpassed target for both WHO recommended AFP quality indicators.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The performance of&#xa0;Kenya's AFP surveillance system surpassed the minimum WHO recommended targets for both non-polio AFP rate and stool adequacy during the period studied. In order&#xa0;to strengthen the country's polio free status, health worker's awareness on AFP surveillance and active case search should be strengthened in least performing counties to improve case detection. Similar analyses should be done at the sub-county level to uncover underperformance that might have been hidden by county level analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tesfaye</LastName><ForeName>Brook</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8426-3788</Identifier><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya. balagerusew7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sowe</LastName><ForeName>Alieu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kisangau</LastName><ForeName>Ngina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogange</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntoburi</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nekar</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Polio Surge Consultant, African Field Epidemiology Network, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muitherero</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camara</LastName><ForeName>Yaya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gathenji</LastName><ForeName>Carolyne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Horn of Africa Polio Eradication Coordination Office, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langat</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Disease Surveillance and Response, Ministry of Health, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sergon</LastName><ForeName>Kibet</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limo</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Disease Surveillance and Response, Ministry of Health, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nzunza</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kenya Medical Research Institute, Center for Virus Research, Ministry of Health, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiptoon</LastName><ForeName>Shem</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kareko</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Disease Surveillance and Response, Ministry of Health, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onuekwusi</LastName><ForeName>Iheoma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>World Health Organization, Kenya Country Office, United Nations Office in Nairobi (UNON), Gigiri Complex, Block U, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="Y">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040362" MajorTopicYN="N">Geographic Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007630" MajorTopicYN="N" Type="Geographic">Kenya</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Flaccid Paralysis&#xa0;(AFP)</Keyword><Keyword MajorTopicYN="N">Immunization</Keyword><Keyword MajorTopicYN="N">Kenya</Keyword><Keyword MajorTopicYN="N">Polio</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32811467</ArticleId><ArticleId IdType="pmc">PMC7437168</ArticleId><ArticleId IdType="doi">10.1186/s12879-020-05319-6</ArticleId><ArticleId IdType="pii">10.1186/s12879-020-05319-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Organization WH . WHO-recommended standards for surveillance of selected vaccine preventable diseases. Geneva: World Health Organization; 1999.</Citation></Reference><Reference><Citation>Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG. Surveillance systems to track progress toward polio eradication&#x2014;worldwide, 2015&#x2013;2016. MMWR Morb Mortal Wkly Rep. 2017;66(13):359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657908</ArticleId><ArticleId IdType="pubmed">28384129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison&#x2019;s principles of internal medicine. New York City: McGraw-Hill Professional Publishing; 2018.</Citation></Reference><Reference><Citation>Sevencan F, Ertem MA, &#xd6;ner H, Aras-K&#x131;l&#x131;n&#xe7; E, K&#xf6;se O&#xd6;, Demircio&#x11f;lu S, et al. Acute flaccid paralysis surveillance in Southeastern Turkey, 1999&#x2013;2010. Turk J Pediatr. 2013;55(3):283&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan KJ, Ray CG. Medical microbiology. New York: McGraw Hill; 2004. p. 370.</Citation></Reference><Reference><Citation>Saleh J-EA, Vaz RG, Braka F, Abdelrahim K, Ningi AI. A critical look at 2015 acute flaccid paralysis (AFP) surveillance core indicators of Bauchi state, Nigeria. Sci J Public Health. 2016;4(4):326&#x2013;329.</Citation></Reference><Reference><Citation>Lam R, Tsang T, Chan K, Lau Y, Lim W, Lam T, et al. Surveillance of acute flaccid paralysis in Hong Kong: 1997 to 2002. Hong Kong Med J. 2005;11(3):164&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">15951581</ArticleId></ArticleIdList></Reference><Reference><Citation>Davarpanah M, Bakhtiari H, Mehrbani D, KHADEM AF. A 12-years surveillance of poliomyelitis and acute flaccid paralysis in Fars Province, Southern Iran. 2008.</Citation></Reference><Reference><Citation>Frauenthal HW, Manning JVV. A manual of infantile paralysis: with modern methods of treatment, including reports based on the treatment of three thousand cases. Philadelphia: FA Davis Company; 1914.</Citation></Reference><Reference><Citation>Davis F. Passage through crisis: polio victims and their families. Abingdon: Routledge; 2017.</Citation></Reference><Reference><Citation>Halstead LS, Rossi CD. New problems in old polio patients: results of a survey of 539 polio survivors. Orthopedics. 1985;8(7):845&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">3867865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman MM, Meyer SA, Mulumba A, Nyembwe M, Riziki Y, Mbule A, et al. Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010&#x2013;2012. J Infect Dis. 2014;210(suppl_1):S50&#x2013;S61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10448638</ArticleId><ArticleId IdType="pubmed">25316874</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegegne SG, MKanda P, Yehualashet YG, Erbeto TB, Touray K, Nsubuga P, et al. Implementation of a systematic accountability framework in 2014 to improve the performance of the Nigerian Polio Program. J Infect Dis. 2016;213(suppl_3):S96&#x2013;S100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818547</ArticleId><ArticleId IdType="pubmed">26823334</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostin LO. International infectious disease law: revision of the World Health Organization&#x2019;s International Health Regulations. JAMA. 2004;291(21):2623&#x2013;2627.</Citation><ArticleIdList><ArticleId IdType="pubmed">15173154</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Initiative GPE . Global polio eradication initiative: strategic plan 2010&#x2013;2012. Geneva: World Health Organization; 2010.</Citation></Reference><Reference><Citation>Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, et al. Progress toward polio eradication&#x2014;worldwide, 2013&#x2013;2014. MMWR Morb Mortal Wkly Rep. 2014;63(21):468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779464</ArticleId><ArticleId IdType="pubmed">24871252</ArticleId></ArticleIdList></Reference><Reference><Citation>Initiative GPE. Global polio surveillance action plan, 2018&#x2013;2020. Geneva: Global Polio Eradication Initiative; 2019.</Citation></Reference><Reference><Citation>Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF, et al. Progress toward polio eradication&#x2014;worldwide, January 2017&#x2013;march 2019. Morb Mortal Wkly Rep. 2019;68(20):458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532951</ArticleId><ArticleId IdType="pubmed">31120868</ArticleId></ArticleIdList></Reference><Reference><Citation>Available from: https://reliefweb.int/disaster/ep-2013-000064-ken. Accessed 1 May 2019.</Citation></Reference><Reference><Citation>Hornsby C. Kenya: a history since independence. London: IB Tauris; 2013.</Citation></Reference><Reference><Citation>Ertem M, Sarac A, Tumay S. Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998. Public Health. 2000;114(4):286&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">10962593</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH . Guidelines on responding to the detection of wild poliovirus in the WHO European region. Copenhagen: WHO Regional Office for Europe; 2007.</Citation></Reference><Reference><Citation>Odoom JK, Ntim NAA, Sarkodie B, Addo J, Minta-Asare K, Obodai E, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009&#x2013;2013. BMC Public Health. 2014;14(1):687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4094438</ArticleId><ArticleId IdType="pubmed">24996415</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita I, Nakane M, Fenner F. Is polio eradication realistic? Science. 2006;312(5775):852&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">16690846</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH Acute flaccid paralysis (AFP) surveillance: the surveillance strategy for poliomyelitis eradication. Wkly Epidemiol Rec. 1998;73(16):113&#x2013;114.</Citation></Reference><Reference><Citation>Kohler KA, Hlady WG, Banerjee K, Gupta D, Francis P, Durrani S, et al. Compatible poliomyelitis cases in India during 2000. Bull World Health Organ. 2003;81:2&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572314</ArticleId><ArticleId IdType="pubmed">12640469</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuzwayo LS, Kuonza LR, Ngcobo NJ. Evaluating the acute flaccid paralysis surveillance system in South Africa, 2005&#x2013;2009-an analysis of secondary data. Pan Afr Med J. 2013;14(1):86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641932</ArticleId><ArticleId IdType="pubmed">23646222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, et al. World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal. 2013;33(4):664&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">23520991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassey BE, Gasasira A, Mitula P, Frankson UU, Adeniji JA. Surveillance of acute flaccid paralysis in Akwa Ibom State, Nigeria 2004-2009. Pan Afr Med J. 2011;9(1):32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3215554</ArticleId><ArticleId IdType="pubmed">22145065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisu AW, Johnson TM, Craig K, Mkanda P, Banda R, Tegegne SG, et al. Strategies for improving polio surveillance performance in the security-challenged Nigerian States of Adamawa, Borno, and Yobe during 2009&#x2013;2014. J Infect Dis. 2016;213(suppl_3):S136&#x2013;S1S9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818552</ArticleId><ArticleId IdType="pubmed">26655842</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Errico MM, Barbadoro P, Bacelli S, Esposto E, Moroni V, Scaccia F, et al. Surveillance of acute flaccid paralysis in the marches region (Italy): 1997&#x2013;2007. BMC Infect Dis. 2008;8(1):135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2576306</ArticleId><ArticleId IdType="pubmed">18844987</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegegne AA, Fiona B, Shebeshi ME, Hailemariam FT, Aregay AK, Beyene B, et al. Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005&#x2013;2015: progress and challenges. Pan Afr Med J. 2017;27(Suppl 2):10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578723</ArticleId><ArticleId IdType="pubmed">28890751</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe9; J-M, Castillo C, Castro RG, de Quadros CA. Epidemiologic study of Guillain-Barr&#xe9; syndrome in children&lt; 15 years of age in Latin America. J Infect Dis. 1997;175(Supplement_1):S160&#x2013;S1S4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9203710</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Polio endgame: the global introduction of inactivated polio vaccine. Expert Rev Vaccines. 2015;14(5):749&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pubmed">25597843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabin A, Boulger L. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand. 1973;1(2):115&#x2013;118.</Citation></Reference><Reference><Citation>Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine. 2013;31(12):1560&#x2013;1568.</Citation><ArticleIdList><ArticleId IdType="pubmed">23196207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, et al. Progress toward poliomyelitis eradication in Nigeria. J Infect Dis. 2014;210(suppl_1):S40&#x2013;SS9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11177795</ArticleId><ArticleId IdType="pubmed">25316862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, et al. Recombinant vaccine&#x2013;derived poliovirus in Madagascar. Emerg Infect Dis. 2003;9(7):885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3023450</ArticleId><ArticleId IdType="pubmed">12899139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib ZA, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">11896235</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>